Sun Pharma: Sanjay Asher retires, Rama Bijapurkar joins audit committee

Sun Pharmaceutical Industries (BSE: SUNPHARMA) announced changes to its Board of Directors and Audit Committee today. Independent Director Sanjay Asher (DIN: 00008221) will retire from the Board after the close of business hours on March 31, 2025, upon completion of his term. Concurrently, the Board approved the appointment of Ms. Rama Bijapurkar (DIN: 00001835), also an Independent Director, to the Audit Committee, effective immediately. This appointment fills the vacancy created by Mr. Asher's retirement. The decisions were made during a board meeting held on March 31, 2025, which commenced at 3:30 P.M. and concluded at 5:40 P.M.